 |
cetuximab |
|---|---|
| Trade Name | Erbitux |
| Orphan Indication | Squamous cell carcinoma of head and neck |
| USA Market Approval | USA |
| USA Designation Date | 2000-07-03 00:00:00 |
| Sponsor | ImClone Systems Incorporated;33 ImClone Drive;Branchburg, New Jersey, 08876 |
| |
cetuximab |
|---|---|
| Trade Name | Erbitux |
| Orphan Indication | Squamous cell carcinoma of head and neck |
| USA Market Approval | USA |
| USA Designation Date | 2000-07-03 00:00:00 |
| Sponsor | ImClone Systems Incorporated;33 ImClone Drive;Branchburg, New Jersey, 08876 |